Spending on prescription medicines in the U.S. fell for the first time in decades last year, slipping as cash-strapped consumers continued to cut back on use of health care services.
The Supreme Court struggled Monday with whether it should allow federal officials to challenge deals between pharmaceutical corporations and their generic drug competitors that the government says could keep cheaper forms of medicine off the American market for longer periods of time.
CVS Caremark Corp. said Tuesday that its third-quarter earnings climbed 16 percent. The drugstore operator and pharmacy benefits manager posted revenue increases in both businesses, benefiting from new customers won from rivals, and raised its full-year earnings outlook.
If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know.
Growth in global spending on medications will slow markedly over the next four years due to a slew of new low-cost generic drugs coming to pharmacies in the U.S. and other developed countries, along with slower increases in what those countries spend on brand-name drugs, according to a new forecast.
The Supreme Court's decision Thursday to uphold President Barack Obama's historic overhaul is expected to be a boon to most of the health care industry by making coverage more affordable for millions of uninsured Americans.
Finding the right nursing home for an elderly loved one is a daunting task. And it's one most of us will face, as two-thirds of people over 65 will need nursing home care, at least temporarily, according to AARP.
Pfizer Inc.'s first-quarter profit fell 19 percent, because of legal and other charges and new generic competition to blockbuster cholesterol pill Lipitor that cut the drugmaker's U.S. sales by 15 percent.
Drugmaker Merck & Co. said Friday that its first-quarter profit jumped 67 percent despite lower-than-expected sales, due to lower spending on production, marketing and research as well as an arbitration charge a year ago.
DebugScreen: mobile
{
"author": {
"name": "Linda A Johnson",
"webUrl": "/author/profile/linda-a-johnson/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 18,
"social": [],
"articles": [
{
"uri": "/2013/06/19/wiser-medication-use-could-save-213-billion/",
"title": "Wiser medication use could save $213 billion",
"byline": "Linda A. Johnson",
"kicker": "",
"prettyDate": "June 19, 2013",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson/",
"name": "Linda A. Johnson"
}
],
"kickerNode": [],
"summary": "A new study indicates the U.S. health care system could save big time from curbing medication overuse, underuse and other flaws in care.",
"body": null
},
{
"uri": "/2013/05/09/u-s-medicine-spending-shows-rare-dip-in-2012/",
"title": "U.S. medicine spending shows rare dip in 2012",
"byline": " Linda A. Johnson ",
"kicker": "",
"prettyDate": "May 09, 2013",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson/",
"name": "Linda A. Johnson"
}
],
"kickerNode": [],
"summary": "Spending on prescription medicines in the U.S. fell for the first time in decades last year, slipping as cash-strapped consumers continued to cut back on use of health care services.",
"body": null
},
{
"uri": "/2013/03/25/high-court-weighs-drug-companies-generics-policy/",
"title": "High court weighs drug companies' generics policy",
"byline": "Jesse J. Holland and Linda A. Johnson, Associated Press",
"kicker": "",
"prettyDate": "March 25, 2013",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/jesse-j-holland/",
"name": "Jesse J. Holland"
},
{
"webUrl": "/author/profile/linda-a-johnson-associated-press/",
"name": "Linda A. Johnson, Associated Press"
}
],
"kickerNode": [],
"summary": "The Supreme Court struggled Monday with whether it should allow federal officials to challenge deals between pharmaceutical corporations and their generic drug competitors that the government says could keep cheaper forms of medicine off the American market for longer periods of time.",
"body": null
},
{
"uri": "/2012/11/06/cvs-caremark-profits-up-on-strong-sales/",
"title": "CVS Caremark profits up on strong sales",
"byline": "Linda A. Johnson",
"kicker": "",
"prettyDate": "November 06, 2012",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson/",
"name": "Linda A. Johnson"
}
],
"kickerNode": [],
"summary": "CVS Caremark Corp. said Tuesday that its third-quarter earnings climbed 16 percent. The drugstore operator and pharmacy benefits manager posted revenue increases in both businesses, benefiting from new customers won from rivals, and raised its full-year earnings outlook.",
"body": null
},
{
"uri": "/2012/08/20/new-coupons-aim-to-keep-people-off-generic-drugs/",
"title": "New coupons aim to keep people off generic drugs",
"byline": "Linda A. Johnson, AP Business Writer",
"kicker": "",
"prettyDate": "August 20, 2012",
"timeToRead": "9 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson-ap-business-writer/",
"name": "Linda A. Johnson, AP Business Writer"
}
],
"kickerNode": [],
"summary": "If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know.",
"body": null
},
{
"uri": "/2012/07/12/spending-on-drugs-will-slow-until-2016/",
"title": "Spending on drugs will slow until 2016",
"byline": "Linda A. Johnson",
"kicker": "",
"prettyDate": "July 12, 2012",
"timeToRead": "3 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson/",
"name": "Linda A. Johnson"
}
],
"kickerNode": [],
"summary": "Growth in global spending on medications will slow markedly over the next four years due to a slew of new low-cost generic drugs coming to pharmacies in the U.S. and other developed countries, along with slower increases in what those countries spend on brand-name drugs, according to a new forecast.",
"body": null
},
{
"uri": "/2012/06/28/high-court-ruling-benefits-most-health-care-niches/",
"title": "High court ruling benefits most health care niches",
"byline": "Linda A. Johnson, AP Business Writer",
"kicker": "",
"prettyDate": "June 28, 2012",
"timeToRead": "6 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson-ap-business-writer/",
"name": "Linda A. Johnson, AP Business Writer"
}
],
"kickerNode": [],
"summary": "The Supreme Court's decision Thursday to uphold President Barack Obama's historic overhaul is expected to be a boon to most of the health care industry by making coverage more affordable for millions of uninsured Americans.",
"body": null
},
{
"uri": "/2012/05/23/tips-to-pick-the-best-nursing-home-for-a-loved-one/",
"title": "Tips to pick the best nursing home for a loved one",
"byline": "Linda A. Johnson",
"kicker": "",
"prettyDate": "May 23, 2012",
"timeToRead": "5 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson/",
"name": "Linda A. Johnson"
}
],
"kickerNode": [],
"summary": "Finding the right nursing home for an elderly loved one is a daunting task. And it's one most of us will face, as two-thirds of people over 65 will need nursing home care, at least temporarily, according to AARP.",
"body": null
},
{
"uri": "/2012/05/01/pfizer-first-quarter-profit-falls-19-percent/",
"title": "Pfizer first-quarter profit falls 19 percent",
"byline": "Linda A. Johnson",
"kicker": "",
"prettyDate": "May 01, 2012",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson/",
"name": "Linda A. Johnson"
}
],
"kickerNode": [],
"summary": "Pfizer Inc.'s first-quarter profit fell 19 percent, because of legal and other charges and new generic competition to blockbuster cholesterol pill Lipitor that cut the drugmaker's U.S. sales by 15 percent.",
"body": null
},
{
"uri": "/2012/04/27/merck-posts-big-first-quarter-profit-jump/",
"title": "Merck posts big first-quarter profit jump",
"byline": "Linda A. Johnson",
"kicker": "",
"prettyDate": "April 27, 2012",
"timeToRead": "4 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/linda-a-johnson/",
"name": "Linda A. Johnson"
}
],
"kickerNode": [],
"summary": "Drugmaker Merck & Co. said Friday that its first-quarter profit jumped 67 percent despite lower-than-expected sales, due to lower spending on production, marketing and research as well as an arbitration charge a year ago.",
"body": null
}
]
}
}
